ROBERT E. ANDERSON, M.D.; KENZO ISHIDA, M.D.
A causal relation between leukemia and ionizing radiation has been well documented in both man and laboratory animals (1-4). Similarly, there is an increased frequency of myelofibrosis with myeloid metaplasia in survivors of the atomic bomb in Hiroshima (5). Since a close relationship between the myeloproliferative disorders and malignant lymphomas is now generally accepted, the occurrence of the malignant lymphomas might be expected to be increased in survivors of the atomic bomb.
This report concerns the prevalence of Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma, and multiple myeloma in the surgical and autopsy material examined at the Atomic Bomb Casualty Commission
ANDERSON RE, ISHIDA K. Malignant Lymphoma in Survivors of the Atomic Bomb in Hiroshima. Ann Intern Med. 1964;61:853–862. doi: 10.7326/0003-4819-61-5-853
Download citation file:
© 2019
Published: Ann Intern Med. 1964;61(5_Part_1):853-862.
DOI: 10.7326/0003-4819-61-5-853
Hematology/Oncology, Leukemia/Lymphoma.
Results provided by: